Zenapax (daclizumab) reduces the incidence of acute rejection episodes andimproves patient survival following renal transplantation

Authors
Ekberg, H Backman, L Tufveson, G Tyden, G
Citation
H. Ekberg et al., Zenapax (daclizumab) reduces the incidence of acute rejection episodes andimproves patient survival following renal transplantation, TRANSPLAN P, 31(1-2), 1999, pp. 267-268
Citations number
12
Categorie Soggetti
Surgery,"Medical Research Diagnosis & Treatment
Journal title
TRANSPLANTATION PROCEEDINGS
ISSN journal
00411345 → ACNP
Volume
31
Issue
1-2
Year of publication
1999
Pages
267 - 268
Database
ISI
SICI code
0041-1345(199902/03)31:1-2<267:Z(RTIO>2.0.ZU;2-R